Organic Letters
Letter
Scheme 2. Synthetic Application
REFERENCES
■
(1) For selected reviews about tetronic acids, see: (a) Zografos, A. L.;
Georgiadis, D. Synthesis 2006, 2006, 3157. (b) Schobert, R.; Schlenk,
A. Bioorg. Med. Chem. 2008, 16, 4203. (c) Vieweg, L.; Reichau, S.;
Schobert, R.; Leadlay, P. F.; Sussmuth, R. D. Nat. Prod. Rep. 2014, 31,
̈
1554. (d) Georgiadis, D. In Natural Lactones and Lactams; Janecki, T.,
Ed.; Wiley: Weinheim, 2014; p 1.
(2) (a) Foden, F. R.; McCormick, J.; O’Mant, M. J. Med. Chem. 1975,
18, 199. (b) Rehse, K.; Wagenknecht, J.; Rietbrock, N. Arch. Pharm.
(Weinheim, Ger.) 1978, 311, 986. (c) Ibi, A.; Taniguchi, E.; Maekawa,
K. Agric. Biol. Chem. 1979, 43, 1641. (d) Davies, D. H.; Snape, E. W.;
Suter, P. J.; King, T. J.; Falshaw, C. P. J. Chem. Soc., Chem. Commun.
1981, 1073. (e) Witiak, D. T.; Kokrady, S. S.; Patel, S. T.; Akbar, H.;
Feller, D. R.; Newman, H. A. I. J. Med. Chem. 1982, 25, 90. (f) Rehse,
K.; Emisch, U. Arch. Pharm. (Weinheim, Ger.) 1983, 316, 115.
(g) Vanwagenen, B. C.; Cardellina, J. H., II Tetrahedron 1986, 42,
1117. (h) Booth, P. M.; Fox, C. M. J.; Ley, S. V. J. Chem. Soc., Perkin
Trans. 1 1987, 121. (i) Capon, R. J.; MacLeod, J. K. Aust. J. Chem.
1987, 40, 1327. (j) Matsumoto, M.; Kawamura, Y.; Yoshimura, Y.;
Terui, Y.; Nakai, H.; Yoshida, T.; Shoji, J. J. Antibiot. 1990, 43, 739.
(k) Luk, K.; Readshaw, S. A. J. Chem. Soc., Perkin Trans. 1 1991, 1641.
(l) Kusumi, T.; Ichikawa, A.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113,
8947. (m) Ley, S. V.; Trudell, M. L.; Wadsworth, D. J. Tetrahedron
1991, 47, 8285. (n) Hata, G.; Kawai, H.; Kaneko, T.; Imaoka, T.;
Kitano, Y.; Mutoh, M.; Imanishi, H. Chem. Lett. 1993, 22, 529.
(o) Roggo, B. E.; Petersen, F.; Delmendo, R.; Jenny, H.-B.; Peter, H.
H.; Roesel, J. J. Antibiot. 1994, 47, 136. (p) Sodeoka, M.; Sampe, R.;
Kagamizono, T.; Osada, H. Tetrahedron Lett. 1996, 37, 8775.
(q) Sodeoka, M.; Sampe, R.; Kojima, S.; Baba, Y.; Morisaki, N.;
Hashimoto, Y. Chem. Pharm. Bull. 2001, 49, 206. (r) Bretschneider, T.;
Benet-Buchholz, J.; Fischer, R.; Nauen, R. Chimia 2003, 57, 697.
(s) Antane, S.; Caufield, C. E.; Hu, W.; Keeney, D.; Labthavikul, P.;
Morris, K.; Naughton, S. M.; Petersen, P. J.; Rasmussen, B. A.; Singh,
G.; Yang, Y. Bioorg. Med. Chem. Lett. 2006, 16, 176. (t) Peukert, S.;
Sun, Y.; Zhang, R.; Hurley, B.; Sabio, M.; Shen, X.; Gray, C.; Dzink-
Fox, J.; Tao, J.; Cebula, R.; Wattanasin, S. Bioorg. Med. Chem. Lett.
2008, 18, 1840. (u) Hu, Y.; Wang, J.; Lu, A.; Yang, C. Bioorg. Med.
Chem. Lett. 2014, 24, 3772. (v) Murray, E. J.; Crowley, R. C.; Truman,
A.; Clarke, S. R.; Cottam, J. A.; Jadhav, G. P.; Steele, V. R.; O’Shea, P.;
Lindholm, C.; Cockayne, A.; Chhabra, S. R.; Chan, W. C.; Williams, P.
J. Med. Chem. 2014, 57, 2813. (w) Zhang, P.; Li, X.-M.; Wang, J.-N.;
Li, X.; Wang, B.-G. Phytochem. Lett. 2015, 11, 85. (x) Carneiro, V. M.
T.; Trivella, D. B. B.; Scorsato, V.; Beraldo, V. L.; Dias, M. P.; Sobreira,
T. J. P.; Aparicio, R.; Pilli, R. A. Eur. J. Med. Chem. 2015, 97, 42.
(y) Zhang, L.-H.; Feng, B.-M.; Zhao, Y.-Q.; Sun, Y.; Liu, B.; Liu, F.;
Chen, G.; Bai, J.; Hua, H.-M.; Wang, H.-F.; Pei, Y.-H. Bioorg. Med.
Chem. Lett. 2016, 26, 346. (z) Igarashi, Y.; Matsuoka, N.; In, Y.;
Kataura, T.; Tashiro, E.; Saiki, I.; Sudoh, Y.; Duangmal, K.;
Thamchaipenet, A. Org. Lett. 2017, 19, 1406.
fixation of 1l proceeded to afford the corresponding product 2l
in 73% yield. Demethylation of 2l was performed based on the
conditions of a previous report,14c resulting in aspulvinone E in
98% isolated yield. Overall, the synthesis of aspulvinone E was
achieved in three steps from commercially available materials.
In one previous report,14c the synthesis of aspulvinone E from
pyruvic acid was achieved using a Dieckmann cyclization as a
key step. However, multiple steps were required to synthesize
the cyclization precursor (trifluoroethyl 2-cinnamate), and six
steps were required to synthesize aspulvinone E. Therefore, our
protocol can be regarded as noteworthy in terms of step-
economy.
In conclusion, we have developed a highly efficient synthesis
of tetronic acid derivatives through ynone enolate trapping
carbon dioxide and silver-catalyzed 5-exo-dig selective cycliza-
tion. This sequence allows a facile and versatile access to
functionalized tetronic acid derivatives. Further application of
this reaction to the synthesis of various tetronic acids is
currently underway.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
(3) (a) Willis, C.; Bodio, E.; Bourdreux, Y.; Billaud, C.; Gall, T. L.;
Experimental procedures, analytical data for all new
compounds, and NMR spectra for the products (PDF)
Mioskowski, C. Tetrahedron Lett. 2007, 48, 6421. (b) Iikawa, S.;
Chopin, N.; Pilet, G.; Bouillon, J.-P.; Med
2013, 54, 4577. (c) Chopin, N.; Yanai, H.; Iikawa, S.; Pilet, G.;
Bouillon, J.-P.; Medebielle, M. Eur. J. Org. Chem. 2015, 2015, 6259.
(d) Manchoju, A.; Pansare, S. V. Org. Lett. 2016, 18, 5952.
(4) (a) Korovitch, A.; Le Roux, A.; Barbault, F.; Hemadi, M.; Ha-
́
ebielle, M. Tetrahedron Lett.
́
AUTHOR INFORMATION
■
Corresponding Author
ORCID
́
Duong, N.-T.; Lion, C.; Wagner, A.; Chahine, J.-M. E. H. Inorg. Chim.
Acta 2013, 394, 45. (b) Le Roux, A.; Meunier, S.; Le Gall, T.; Denis, J.-
M.; Bischoff, P.; Wagner, A. ChemMedChem 2011, 6, 561. (c) Yang,
W.; Liu, J.; Zhang, H. Tetrahedron Lett. 2010, 51, 4874. (d) Habrant,
Notes
D.; Poigny, S.; Seg
Strehle, A.; Saladin, R.; Meunier, S.; Mioskowski, C.; Wagner, A. J.
Med. Chem. 2009, 52, 2454. (e) Perez, M.; Perez, D. I.; Martínez, A.;
Castro, A.; Gomez, G.; Fall, Y. Chem. Commun. 2009, 3252.
́
ur-Derai, M.; Brunel, Y.; Heurtaux, B.; Le Gall, T.;
The authors declare no competing financial interest.
́
́
́
ACKNOWLEDGMENTS
■
(f) Mallinger, A.; Le Gall, T.; Mioskowski, C. J. Org. Chem. 2009,
74, 1124. (g) Bourdreux, Y.; Bodio, E.; Willis, C.; Billaud, C.; Le Gall,
T.; Mioskowski, C. Tetrahedron 2008, 64, 8930.
This paper is dedicated to Professor Emeritus Teruaki
Mukaiyama of The University of Tokyo in celebration of his
90th birthday.
(5) Yoshikawa, T.; Shindo, M. Org. Lett. 2009, 11, 5378.
C
Org. Lett. XXXX, XXX, XXX−XXX